Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses

Purinergic Signalling

Volumn 9, Issue 3, 2013, Pages 285-306

  Jacob, Fenila ^a   Novo, Claudina Pérez ^a   Bachert, Claus ^a   Van Crombruggen, Koen ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

ATP; Extracellular nucleotides; Inflammatory cells; P2 receptors; Regulation of immune responses

Indexed keywords

ADENOSINE TRIPHOSPHATE; CD39 ANTIGEN; INFLAMMASOME; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; L SELECTIN; PURINERGIC P2 RECEPTOR; PURINERGIC P2X1 RECEPTOR; PURINERGIC P2X3 RECEPTOR; PURINERGIC P2X4 RECEPTOR; PURINERGIC P2X7 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ACTIN POLYMERIZATION; CALCIUM MOBILIZATION; CELL DEATH; CELL MATURATION; CHEMOTAXIS; CYTOTOXICITY; DENDRITIC CELL; EOSINOPHIL; GIANT CELL; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INFLAMMATORY CELL; LYMPHOCYTE; MACROPHAGE; MAST CELL; MEDIATOR RELEASE; NEUTROPHIL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

ANIMALS; HUMANS; INFLAMMATION; LEUKOCYTES; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION;

EID: 84883458893     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-013-9357-4     Document Type: Review

References (237)

1. Lotze MT, Zeh HJ, Rubartelli A, Sparvero LJ, Amoscato AA et al (2007) The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol Rev 220: 60-81.
2. Rubartelli A, Lotze MT (2007) Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox. Trends Immunol 28(10): 429-436.
3. Khakh BS, North RA (2006) P2X receptors as cell-surface ATP sensors in health and disease. Nature 442(7102): 527-532.
4. Myrtek D, Idzko M (2007) Chemotactic activity of extracellular nucleotideson human immune cells. Purinergic Signal 3(1-2): 5-11.
5. Vitiello L, Gorini S, Rosano G, la Sala A (2012) Immunoregulation through extracellular nucleotides. Blood 120(3): 511-518.
6. Weber FC, Esser PR, Muller T, Ganesan J, Pellegatti P et al (2010) Lack of the purinergic receptor P2X(7) results in resistance to contact hypersensitivity. J Exp Med 207(12): 2609-2619.
7. Wilhelm K, Ganesan J, Muller T, Durr C, Grimm M et al (2010) Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R. Nat Med 16(12): 1434-1438.
8. Barbera-Cremades M, Baroja-Mazo A, Gomez AI, Machado F, Di Virgilio F et al (2012) P2X7 receptor-stimulation causes fever via PGE2 and IL-1beta release. FASEB J 26(7): 2951-2962.
9. Di Virgilio F, Chiozzi P, Ferrari D, Falzoni S, Sanz JM et al (2001) Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 97(3): 587-600.
10. Ferrari D, la Sala A, Panther E, Norgauer J, Di Virgilio F et al (2006) Activation of human eosinophils via P2 receptors: novel findings and future perspectives. J Leukoc Biol 79(1): 7-15.
11. Bodin P, Burnstock G (2001) Purinergic signalling: ATP release. Neurochem Res 26(8-9): 959-969.
12. Junger WG (2011) Immune cell regulation by autocrine purinergic signalling. Nat Rev Immunol 11(3): 201-212.
13. Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL et al (2006) International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58(3): 281-341.
14. Jarvis MF, Khakh BS (2009) ATP-gated P2X cation-channels. Neuropharmacology 56(1): 208-215.
15. Burnstock G, Knight GE (2004) Cellular distribution and functions of P2 receptor subtypes in different systems. Int Rev Cytol 240: 31-304.
16. Burnstock G (2007) Purine and pyrimidine receptors. Cell Mol Life Sci 64(12): 1471-1483.
17. Volonte C, Amadio S, D'Ambrosi N, Colpi M, Burnstock G (2006) P2 receptor web: complexity and fine-tuning. Pharmacol Ther 112(1): 264-280.
18. Rayah A, Kanellopoulos JM, Di Virgilio F (2012) P2 receptors and immunity. Microbes Infect 14(14): 1254-1262.
19. Mohanty JG, Raible DG, McDermott LJ, Pelleg A, Schulman ES (2001) Effects of purine and pyrimidine nucleotides on intracellular Ca2+ in human eosinophils: activation of purinergic P2Y receptors. J Allergy Clin Immunol 107(5): 849-855.
20. Sak K, Boeynaems JM, Everaus H (2003) Involvement of P2Y receptors in the differentiation of haematopoietic cells. J Leukoc Biol 73(4): 442-447.
21. Jin J, Dasari VR, Sistare FD, Kunapuli SP (1998) Distribution of P2Y receptor subtypes on haematopoietic cells. Br J Pharmacol 123(5): 789-794.
22. Bulanova E, Budagian V, Orinska Z, Hein M, Petersen F et al (2005) Extracellular ATP induces cytokine expression and apoptosis through P2X7 receptor in murine mast cells. J Immunol 174(7): 3880-3890.
23. Feng C, Mery AG, Beller EM, Favot C, Boyce JA (2004) Adenine nucleotides inhibit cytokine generation by human mast cells through a Gs-coupled receptor. J Immunol 173(12): 7539-7547.
24. Humphreys BD, Dubyak GR (1998) Modulation of P2X7 nucleotide receptor expression by pro- and anti-inflammatory stimuli in THP-1 monocytes. J Leukoc Biol 64(2): 265-273.
25. Gu B, Bendall LJ, Wiley JS (1998) Adenosine triphosphate-induced shedding of CD23 and l-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases. Blood 92(3): 946-951.
26. Chen JR, Gu BJ, Dao LP, Bradley CJ, Mulligan SP et al (1999) Transendothelial migration of lymphocytes in chronic lymphocytic leukaemia is impaired and involved down-regulation of both l-selectin and CD23. Br J Haematol 105(1): 181-189.
27. Amulic B, Cazalet C, Hayes GL, Metzler KD, Zychlinsky A (2012) Neutrophil function: from mechanisms to disease. Annu Rev Immunol 30: 459-489.
28. Sadik CD, Kim ND, Luster AD (2011) Neutrophils cascading their way to inflammation. Trends Immunol 32(10): 452-460.
29. Axtell RA, Sandborg RR, Smolen JE, Ward PA, Boxer LA (1990) Exposure of human neutrophils to exogenous nucleotides causes elevation in intracellular calcium, transmembrane calcium fluxes, and an alteration of a cytosolic factor resulting in enhanced superoxide production in response to FMLP and arachidonic acid. Blood 75(6): 1324-1332.
30. Ward PA, Cunningham TW, McCulloch KK, Johnson KJ (1988) Regulatory effects of adenosine and adenine nucleotides on oxygen radical responses of neutrophils. Lab Investig 58(4): 438-447.
31. 2-. responses in stimulated human neutrophils. Identification of platelet factor as adenine nucleotide. Lab Investig 58(1): 37-47.
32. Bengtsson T, Zalavary S, Stendahl O, Grenegard M (1996) Release of oxygen metabolites from chemoattractant-stimulated neutrophils is inhibited by resting platelets: role of extracellular adenosine and actin polymerization. Blood 87(10): 4411-4423.
33. Zalavary S, Grenegard M, Stendahl O, Bengtsson T (1996) Platelets enhance Fc(gamma) receptor-mediated phagocytosis and respiratory burst in neutrophils: the role of purinergic modulation and actin polymerization. J Leukoc Biol 60(1): 58-68.
34. Suh BC, Kim JS, Namgung U, Ha H, Kim KT (2001) P2X7 nucleotide receptor mediation of membrane pore formation and superoxide generation in human promyelocytes and neutrophils. J Immunol 166(11): 6754-6763.
35. Vaughan KR, Stokes L, Prince LR, Marriott HM, Meis S et al (2007) Inhibition of neutrophil apoptosis by ATP is mediated by the P2Y11 receptor. J Immunol 179(12): 8544-8553.
36. Martel-Gallegos G, Rosales-Saavedra MT, Reyes JP, Casas-Pruneda G, Toro-Castillo C et al (2010) Human neutrophils do not express purinergic P2X7 receptors. Purinergic Signal 6(3): 297-306.
37. Abbracchio MP, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C et al (2003) Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family. Trends Pharmacol Sci 24(2): 52-55.
38. Chen Y, Shukla A, Namiki S, Insel PA, Junger WG (2004) A putative osmoreceptor system that controls neutrophil function through the release of ATP, its conversion to adenosine, and activation of A2 adenosine and P2 receptors. J Leukoc Biol 76(1): 245-253.
39. Moore DJ, Murdock PR, Watson JM, Faull RL, Waldvogel HJ et al (2003) GPR105, a novel Gi/o-coupled UDP-glucose receptor expressed on brain glia and peripheral immune cells, is regulated by immunologic challenge: possible role in neuroimmune function. Brain Res Mol Brain Res 118(1-2): 10-23.
40. Meshki J, Tuluc F, Bredetean O, Ding Z, Kunapuli SP (2004) Molecular mechanism of nucleotide-induced primary granule release in human neutrophils: role for the P2Y2 receptor. Am J Physiol Cell Physiol 286(2): C264-C271.
41. Scrivens M, Dickenson JM (2006) Functional expression of the P2Y14 receptor in human neutrophils. Eur J Pharmacol 543(1-3): 166-173.
42. Ben YF, Kukulski F, Tremblay A, Sevigny J (2009) Concomitant activation of P2Y(2) and P2Y(6) receptors on monocytes is required for TLR1/2-induced neutrophil migration by regulating IL-8 secretion. Eur J Immunol 39(10): 2885-2894.
43. Lecut C, Frederix K, Johnson DM, Deroanne C, Thiry M et al (2009) P2X1 ion channels promote neutrophil chemotaxis through rho kinase activation. J Immunol 183(4): 2801-2809.
44. Ward PA, Cunningham TW, Johnson KJ (1989) Signal transduction events in stimulated rat neutrophils: effects of adenine nucleotides. Clin Immunol Immunopathol 50(1 Pt 1): 30-41.
45. Cowen DS, Lazarus HM, Shurin SB, Stoll SE, Dubyak GR (1989) Extracellular adenosine triphosphate activates calcium mobilization in human phagocytic leukocytes and neutrophil/monocyte progenitor cells. J Clin Invest 83(5): 1651-1660.
46. Dubyak GR, Cowen DS, Lazarus HM (1988) Activation of the inositol phospholipid signaling system by receptors for extracellular ATP in human neutrophils, monocytes, and neutrophil/monocyte progenitor cells. Ann N Y Acad Sci 551: 218-237.
47. 2- generation. Lab Investig 58(4): 448-453.
48. Merritt JE, Moores KE (1991) Human neutrophils have a novel purinergic P2-type receptor linked to calcium mobilization. Cell Signal 3(3): 243-249.
49. Krause KH, Campbell KP, Welsh MJ, Lew DP (1990) The calcium signal and neutrophil activation. Clin Biochem 23(2): 159-166.
50. Meshki J, Tuluc F, Bredetean O, Garcia A, Kunapuli SP (2006) Signaling pathways downstream of P2 receptors in human neutrophils. Purinergic Signal 2(3): 537-544.
51. Chen Y, Yao Y, Sumi Y, Li A, To UK et al (2010) Purinergic signaling: a fundamental mechanism in neutrophil activation. Sci Signal 3(125): ra45.
52. Verghese MW, Kneisler TB, Boucheron JA (1996) P2U agonists induce chemotaxis and actin polymerization in human neutrophils and differentiated HL60 cells. J Biol Chem 271(26): 15597-15601.
53. Becker EL, Kermode JC, Naccache PH, Yassin R, Marsh ML et al (1985) The inhibition of neutrophil granule enzyme secretion and chemotaxis by pertussis toxin. J Cell Biol 100(5): 1641-1646.
54. Junger WG (2008) Purinergic regulation of neutrophil chemotaxis. Cell Mol Life Sci 65(16): 2528-2540.
55. Chen Y, Corriden R, Inoue Y, Yip L, Hashiguchi N et al (2006) ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 314(5806): 1792-1795.
56. Inoue Y, Chen Y, Hirsh MI, Yip L, Junger WG (2008) A3 and P2Y2 receptors control the recruitment of neutrophils to the lungs in a mouse model of sepsis. Shock 30(2): 173-177.
57. Kukulski F, Ben YF, Lecka J, Kauffenstein G, Levesque SA et al (2009) Extracellular ATP and P2 receptors are required for IL-8 to induce neutrophil migration. Cytokine 46(2): 166-170.
58. Kukulski F, Bahrami F, Ben YF, Lecka J, Martin-Satue M et al (2011) NTPDase1 controls IL-8 production by human neutrophils. J Immunol 187(2): 644-653.
59. Corriden R, Chen Y, Inoue Y, Beldi G, Robson SC et al (2008) Ecto-nucleoside triphosphate diphosphohydrolase 1 (E-NTPDase1/CD39) regulates neutrophil chemotaxis by hydrolyzing released ATP to adenosine. J Biol Chem 283(42): 28480-28486.
60. Kukulski F, Ben YF, Lefebvre J, Warny M, Tessier PA et al (2007) Extracellular nucleotides mediate LPS-induced neutrophil migration in vitro and in vivo. J Leukoc Biol 81(5): 1269-1275.
61. Kukulski F, Ben YF, Bahrami F, Fausther M, Tremblay A et al (2010) Endothelial P2Y2 receptor regulates LPS-induced neutrophil transendothelial migration in vitro. Mol Immunol 47(5): 991-999.
62. Kawamura H, Kawamura T, Kanda Y, Kobayashi T, Abo T (2012) Extracellular ATP-stimulated macrophages produce macrophage inflammatory protein-2 which is important for neutrophil migration. Immunology 136(4): 448-458.
63. Lu DJ, Grinstein S (1990) ATP and guanine nucleotide dependence of neutrophil activation. Evidence for the involvement of two distinct GTP-binding proteins. J Biol Chem 265(23): 13721-13729.
64. Eltzschig HK, Eckle T, Mager A, Kuper N, Karcher C et al (2006) ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine-dependent endothelial cell function. Circ Res 99(10): 1100-1108.
65. Underhill DM, Goodridge HS (2012) Information processing during phagocytosis. Nat Rev Immunol 12(7): 492-502.
66. Murray PJ, Wynn TA (2011) Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 11(11): 723-737.
67. Cohn ZA, Parks E (1967) The regulation of pinocytosis in mouse macrophages. 3. The induction of vesicle formation by nucleosides and nucleotides. J Exp Med 125(3): 457-466.
68. Buisman HP, Steinberg TH, Fischbarg J, Silverstein SC, Vogelzang SA et al (1988) Extracellular ATP induces a large nonselective conductance in macrophage plasma membranes. Proc Natl Acad Sci U S A 85(21): 7988-7992.
69. Greenberg S, Di Virgilio F, Steinberg TH, Silverstein SC (1988) Extracellular nucleotides mediate Ca2+ fluxes in J774 macrophages by two distinct mechanisms. J Biol Chem 263(21): 10337-10343.
70. Steinberg TH, Silverstein SC (1987) Extracellular ATP4- promotes cation fluxes in the J774 mouse macrophage cell line. J Biol Chem 262(7): 3118-3122.
71. Sung SS, Young JD, Origlio AM, Heiple JM, Kaback HR et al (1985) Extracellular ATP perturbs transmembrane ion fluxes, elevates cytosolic [Ca2+], and inhibits phagocytosis in mouse macrophages. J Biol Chem 260(25): 13442-13449.
72. Surprenant A, Rassendren F, Kawashima E, North RA, Buell G (1996) The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272(5262): 735-738.
73. Falzoni S, Munerati M, Ferrari D, Spisani S, Moretti S et al (1995) The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role. J Clin Invest 95(3): 1207-1216.
74. Hickman SE, el KJ, Greenberg S, Schieren I, Silverstein SC (1994) P2Z adenosine triphosphate receptor activity in cultured human monocyte-derived macrophages. Blood 84(8): 2452-2456.
75. Bowler JW, Bailey RJ, North RA, Surprenant A (2003) P2X4, P2Y1 and P2Y2 receptors on rat alveolar macrophages. Br J Pharmacol 140(3): 567-575.
76. Coutinho-Silva R, Ojcius DM, Gorecki DC, Persechini PM, Bisaggio RC et al (2005) Multiple P2X and P2Y receptor subtypes in mouse J774, spleen and peritoneal macrophages. Biochem Pharmacol 69(4): 641-655.
77. Bar I, Guns PJ, Metallo J, Cammarata D, Wilkin F et al (2008) Knockout mice reveal a role for P2Y6 receptor in macrophages, endothelial cells, and vascular smooth muscle cells. Mol Pharmacol 74(3): 777-784.
78. Myrtek D, Muller T, Geyer V, Derr N, Ferrari D et al (2008) Activation of human alveolar macrophages via P2 receptors: coupling to intracellular Ca2+ increases and cytokine secretion. J Immunol 181(3): 2181-2188.
79. Fujiwara N, Kobayashi K (2005) Macrophages in inflammation. Curr Drug Targets Inflamm Allergy 4(3): 281-286.
80. Tonetti M, Sturla L, Bistolfi T, Benatti U, De Flora A (1994) Extracellular ATP potentiates nitric oxide synthase expression induced by lipopolysaccharide in RAW 264. 7 murine macrophages. Biochem Biophys Res Commun 203(1): 430-435.
81. Tonetti M, Sturla L, Giovine M, Benatti U, De Flora A (1995) Extracellular ATP enhances mRNA levels of nitric oxide synthase and TNF-alpha in lipopolysaccharide-treated RAW 264. 7 murine macrophages. Biochem Biophys Res Commun 214(1): 125-130.
82. Perregaux D, Gabel CA (1994) Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J Biol Chem 269(21): 15195-15203.
83. Lemaire I, Leduc N (2003) Purinergic P2X7 receptor function in lung alveolar macrophages: pharmacologic characterization and bidirectional regulation by Th1 and Th2 cytokines. Drug Dev Res 59(1): 118-127.
84. el-Moatassim C, Dubyak GR (1993) Dissociation of the pore-forming and phospholipase D activities stimulated via P2z purinergic receptors in BAC1. 2F5 macrophages. Product inhibition of phospholipase D enzyme activity. J Biol Chem 268(21): 15571-15578.
85. Gudipaty L, Munetz J, Verhoef PA, Dubyak GR (2003) Essential role for Ca2+ in regulation of IL-1beta secretion by P2X7 nucleotide receptor in monocytes, macrophages, and HEK-293 cells. Am J Physiol Cell Physiol 285(2): C286-C299.
86. Perregaux DG, Laliberte RE, Gabel CA (1996) Human monocyte interleukin-1beta posttranslational processing. Evidence of a volume-regulated response. J Biol Chem 271(47): 29830-29838.
87. Ferrari D, Chiozzi P, Falzoni S, Dal Susino M, Melchiorri L et al (1997) Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J Immunol 159(3): 1451-1458.
88. Pelegrin P, Barroso-Gutierrez C, Surprenant A (2008) P2X7 receptor differentially couples to distinct release pathways for IL-1beta in mouse macrophage. J Immunol 180(11): 7147-7157.
89. Verhoef PA, Kertesy SB, Lundberg K, Kahlenberg JM, Dubyak GR (2005) Inhibitory effects of chloride on the activation of caspase-1, IL-1beta secretion, and cytolysis by the P2X7 receptor. J Immunol 175(11): 7623-7634.
90. Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K et al (2006) Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440(7081): 228-232.
91. Di Virgilio F (2007) Liaisons dangereuses: P2X(7) and the inflammasome. Trends Pharmacol Sci 28(9): 465-472.
92. Babelova A, Moreth K, Tsalastra-Greul W, Zeng-Brouwers J, Eickelberg O et al (2009) Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors. J Biol Chem 284(36): 24035-24048.
93. Niemi K, Teirila L, Lappalainen J, Rajamaki K, Baumann MH et al (2011) Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway. J Immunol 186(11): 6119-6128.
94. Petrilli V, Papin S, Dostert C, Mayor A, Martinon F et al (2007) Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ 14(9): 1583-1589.
95. Franchi L, Kanneganti TD, Dubyak GR, Nunez G (2007) Differential requirement of P2X7 receptor and intracellular K+ for caspase-1 activation induced by intracellular and extracellular bacteria. J Biol Chem 282(26): 18810-18818.
96. Cruz CM, Rinna A, Forman HJ, Ventura AL, Persechini PM et al (2007) ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J Biol Chem 282(5): 2871-2879.
97. Sekiyama A, Ueda H, Kashiwamura S, Sekiyama R, Takeda M et al (2005) A stress-induced, superoxide-mediated caspase-1 activation pathway causes plasma IL-18 upregulation. Immunity 22(6): 669-677.
98. Chiozzi P, Murgia M, Falzoni S, Ferrari D, Di Virgilio F (1996) Role of the purinergic P2Z receptor in spontaneous cell death in J774 macrophage cultures. Biochem Biophys Res Commun 218(1): 176-181.
99. Le Feuvre RA, Brough D, Iwakura Y, Takeda K, Rothwell NJ (2002) Priming of macrophages with lipopolysaccharide potentiates P2X7-mediated cell death via a caspase-1-dependent mechanism, independently of cytokine production. J Biol Chem 277(5): 3210-3218.
100. Biswas D, Qureshi OS, Lee WY, Croudace JE, Mura M et al. (2008) ATP-induced autophagy is associated with rapid killing of intracellular mycobacteria within human monocytes/macrophages. BMC Immunol 9: 35.
101. Ernst RK, Guina T, Miller SI (1999) How intracellular bacteria survive: surface modifications that promote resistance to host innate immune responses. J Infect Dis 179(Suppl 2): S326-S330.
102. Lammas DA, Stober C, Harvey CJ, Kendrick N, Panchalingam S et al (1997) ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X7) receptors. Immunity 7(3): 433-444.
103. Punj V, Zaborina O, Dhiman N, Falzari K, Bagdasarian M et al (2000) Phagocytic cell killing mediated by secreted cytotoxic factors of Vibrio cholerae. Infect Immun 68(9): 4930-4937.
104. Zaborina O, Misra N, Kostal J, Kamath S, Kapatral V et al (1999) P2Z-independent and P2Z receptor-mediated macrophage killing by Pseudomonas aeruginosa isolated from cystic fibrosis patients. Infect Immun 67(10): 5231-5242.
105. Coutinho-Silva R, Stahl L, Raymond MN, Jungas T, Verbeke P et al (2003) Inhibition of chlamydial infectious activity due to P2X7R-dependent phospholipase D activation. Immunity 19(3): 403-412.
106. Coutinho-Silva R, da Monteiro CC, Persechini PM, Ojcius DM (2007) The role of P2 receptors in controlling infections by intracellular pathogens. Purinergic Signal 3(1-2): 83-90.
107. Coutinho-Silva R, Correa G, Sater AA, Ojcius DM (2009) The P2X(7) receptor and intracellular pathogens: a continuing struggle. Purinergic Signal 5(2): 197-204.
108. Kawano A, Tsukimoto M, Mori D, Noguchi T, Harada H et al (2012) Regulation of P2X7-dependent inflammatory functions by P2X4 receptor in mouse macrophages. Biochem Biophys Res Commun 420(1): 102-107.
109. Kawano A, Tsukimoto M, Noguchi T, Hotta N, Harada H et al (2012) Involvement of P2X4 receptor in P2X7 receptor-dependent cell death of mouse macrophages. Biochem Biophys Res Commun 419(2): 374-380.
110. Levesque SA, Kukulski F, Enjyoji K, Robson SC, Sevigny J (2010) NTPDase1 governs P2X7-dependent functions in murine macrophages. Eur J Immunol 40(5): 1473-1485.
111. Qu Y, Franchi L, Nunez G, Dubyak GR (2007) Nonclassical IL-1 beta secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages. J Immunol 179(3): 1913-1925.
112. Lopez-Castejon G, Theaker J, Pelegrin P, Clifton AD, Braddock M et al (2010) P2X(7) receptor-mediated release of cathepsins from macrophages is a cytokine-independent mechanism potentially involved in joint diseases. J Immunol 185(4): 2611-2619.
113. Moore SF, MacKenzie AB (2007) Murine macrophage P2X7 receptors support rapid prothrombotic responses. Cell Signal 19(4): 855-866.
114. Gu BJ, Wiley JS (2006) Rapid ATP-induced release of matrix metalloproteinase 9 is mediated by the P2X7 receptor. Blood 107(12): 4946-4953.
115. Elliott MR, Chekeni FB, Trampont PC, Lazarowski ER, Kadl A et al (2009) Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 461(7261): 282-286.
116. McCloskey MA, Fan Y, Luther S (1999) Chemotaxis of rat mast cells toward adenine nucleotides. J Immunol 163(2): 970-977.
117. Kronlage M, Song J, Sorokin L, Isfort K, Schwerdtle T et al (2010) Autocrine purinergic receptor signaling is essential for macrophage chemotaxis. Sci Signal 3(132): ra55.
118. Isfort K, Ebert F, Bornhorst J, Sargin S, Kardakaris R et al (2011) Real-time imaging reveals that P2Y2 and P2Y12 receptor agonists are not chemoattractants and macrophage chemotaxis to complement C5a is phosphatidylinositol 3-kinase (PI3K)- and p38 mitogen-activated protein kinase (MAPK)-independent. J Biol Chem 286(52): 44776-44787.
119. Marques-da-Silva C, Burnstock G, Ojcius DM, Coutinho-Silva R (2011) Purinergic receptor agonists modulate phagocytosis and clearance of apoptotic cells in macrophages. Immunobiology 216(1-2): 1-11.
120. Chiozzi P, Sanz JM, Ferrari D, Falzoni S, Aleotti A et al (1997) Spontaneous cell fusion in macrophage cultures expressing high levels of the P2Z/P2X7 receptor. J Cell Biol 138(3): 697-706.
121. Lemaire I, Falzoni S, Leduc N, Zhang B, Pellegatti P et al (2006) Involvement of the purinergic P2X7 receptor in the formation of multinucleated giant cells. J Immunol 177(10): 7257-7265.
122. Summers dL, Gommerman JL (2012) Fine-tuning of dendritic cell biology by the TNF superfamily. Nat Rev Immunol 12(5): 339-351.
123. Berchtold S, Ogilvie AL, Bogdan C, Muhl-Zurbes P, Ogilvie A et al (1999) Human monocyte derived dendritic cells express functional P2X and P2Y receptors as well as ecto-nucleotidases. FEBS Lett 458(3): 424-428.
124. Ferrari D, la Sala A, Chiozzi P, Morelli A, Falzoni S et al (2000) The P2 purinergic receptors of human dendritic cells: identification and coupling to cytokine release. FASEB J 14(15): 2466-2476.
125. Schnurr M, Toy T, Stoitzner P, Cameron P, Shin A et al (2003) ATP gradients inhibit the migratory capacity of specific human dendritic cell types: implications for P2Y11 receptor signaling. Blood 102(2): 613-620.
126. Skelton L, Cooper M, Murphy M, Platt A (2003) Human immature monocyte-derived dendritic cells express the G protein-coupled receptor GPR105 (KIAA0001, P2Y14) and increase intracellular calcium in response to its agonist, uridine diphosphoglucose. J Immunol 171(4): 1941-1949.
127. Buell G, Chessell IP, Michel AD, Collo G, Salazzo M et al (1998) Blockade of human P2X7 receptor function with a monoclonal antibody. Blood 92(10): 3521-3528.
128. Wilkin F, Duhant X, Bruyns C, Suarez-Huerta N, Boeynaems JM et al (2001) The P2Y11 receptor mediates the ATP-induced maturation of human monocyte-derived dendritic cells. J Immunol 166(12): 7172-7177.
129. la Sala A, Ferrari D, Corinti S, Cavani A, Di Virgilio F et al (2001) Extracellular ATP induces a distorted maturation of dendritic cells and inhibits their capacity to initiate Th1 responses. J Immunol 166(3): 1611-1617.
130. Wilkin F, Stordeur P, Goldman M, Boeynaems JM, Robaye B (2002) Extracellular adenine nucleotides modulate cytokine production by human monocyte-derived dendritic cells: dual effect on IL-12 and stimulation of IL-10. Eur J Immunol 32(9): 2409-2417.
131. Marteau F, Communi D, Boeynaems JM, Suarez GN (2004) Involvement of multiple P2Y receptors and signaling pathways in the action of adenine nucleotides diphosphates on human monocyte-derived dendritic cells. J Leukoc Biol 76(4): 796-803.
132. Schnurr M, Toy T, Shin A, Wagner M, Cebon J et al (2005) Extracellular nucleotide signaling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: a novel role for the cAMP pathway. Blood 105(4): 1582-1589.
133. Schnurr M, Then F, Galambos P, Scholz C, Siegmund B et al (2000) Extracellular ATP and TNF-alpha synergize in the activation and maturation of human dendritic cells. J Immunol 165(8): 4704-4709.
134. Ben AA, Cammarata D, Conley PB, Boeynaems JM, Robaye B (2010) Role of the P2Y12 receptor in the modulation of murine dendritic cell function by ADP. J Immunol 185(10): 5900-5906.
135. Liu QH, Bohlen H, Titzer S, Christensen O, Diehl V et al (1999) Expression and a role of functionally coupled P2Y receptors in human dendritic cells. FEBS Lett 445(2-3): 402-408.
136. Coutinho-Silva R, Persechini PM, Bisaggio RD, Perfettini JL, Neto AC et al (1999) P2Z/P2X7 receptor-dependent apoptosis of dendritic cells. Am J Physiol 276(5 Pt 1): C1139-C1147.
137. Nihei OK, de Carvalho AC, Savino W, Alves LA (2000) Pharmacologic properties of P(2Z)/P2X(7)receptor characterized in murine dendritic cells: role on the induction of apoptosis. Blood 96(3): 996-1005.
138. Girolomoni G, Santantonio ML, Pastore S, Bergstresser PR, Giannetti A et al (1993) Epidermal Langerhans cells are resistant to the permeabilizing effects of extracellular ATP: in vitro evidence supporting a protective role of membrane ATPase. J Investig Dermatol 100(3): 282-287.
139. Idzko M, Dichmann S, Ferrari D, Di Virgilio F, la Sala A et al (2002) Nucleotides induce chemotaxis and actin polymerization in immature but not mature human dendritic cells via activation of pertussis toxin-sensitive P2y receptors. Blood 100(3): 925-932.
140. la Sala A, Sebastiani S, Ferrari D, Di Virgilio F, Idzko M et al (2002) Dendritic cells exposed to extracellular adenosine triphosphate acquire the migratory properties of mature cells and show a reduced capacity to attract type 1T lymphocytes. Blood 99(5): 1715-1722.
141. Muller T, Robaye B, Vieira RP, Ferrari D, Grimm M et al (2010) The purinergic receptor P2Y2 receptor mediates chemotaxis of dendritic cells and eosinophils in allergic lung inflammation. Allergy 65(12): 1545-1553.
142. Idzko M, Hammad H, van NM, Kool M, Willart MA et al (2007) Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat Med 13(8): 913-919.
143. Manthei DM, Jackson DJ, Evans MD, Gangnon RE, Tisler CJ et al (2012) Protection from asthma in a high-risk birth cohort by attenuated P2X(7) function. J Allergy Clin Immunol 130(2): 496-502.
144. Islam SA, Luster AD (2012) T cell homing to epithelial barriers in allergic disease. Nat Med 18(5): 705-715.
145. Batista FD, Harwood NE (2009) The who, how and where of antigen presentation to B cells. Nat Rev Immunol 9(1): 15-27.
146. Vivier E, Ugolini S, Blaise D, Chabannon C, Brossay L (2012) Targeting natural killer cells and natural killer T cells in cancer. Nat Rev Immunol 12(4): 239-252.
147. Baricordi OR, Ferrari D, Melchiorri L, Chiozzi P, Hanau S et al (1996) An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes. Blood 87(2): 682-690.
148. Wiley JS, Dubyak GR (1989) Extracellular adenosine triphosphate increases cation permeability of chronic lymphocytic leukemic lymphocytes. Blood 73(5): 1316-1323.
149. Padeh S, Cohen A, Roifman CM (1991) ATP-induced activation of human B lymphocytes via P2-purinoceptors. J Immunol 146(5): 1626-1632.
150. Conigrave AD, Fernando KC, Gu B, Tasevski V, Zhang W et al (2001) P2Y(11) receptor expression by human lymphocytes: evidence for two cAMP-linked purinoceptors. Eur J Pharmacol 426(3): 157-163.
151. Lee DH, Park KS, Kong ID, Kim JW, Han BG (2006) Expression of P2 receptors in human B cells and Epstein-Barr virus-transformed lymphoblastoid cell lines. BMC Immunol 7: 22.
152. Sluyter R, Barden JA, Wiley JS (2001) Detection of P2X purinergic receptors on human B lymphocytes. Cell Tissue Res 304(2): 231-236.
153. Wang L, Jacobsen SE, Bengtsson A, Erlinge D (2004) P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells. BMC Immunol 5: 16.
154. Scrivens M, Dickenson JM (2005) Functional expression of the P2Y14 receptor in murine T-lymphocytes. Br J Pharmacol 146(3): 435-444.
155. Duhant X, Schandene L, Bruyns C, Gonzalez NS, Goldman M et al (2002) Extracellular adenine nucleotides inhibit the activation of human CD4+ T lymphocytes. J Immunol 169(1): 15-21.
156. Duhant X, Suarez GN, Schandene L, Goldman M, Communi D et al (2005) Molecular mechanisms of extracellular adenine nucleotides-mediated inhibition of human Cd4(+) T lymphocytes activation. Purinergic Signal 1(4): 377-381.
157. el-Moatassim C, Dornand J, Mani JC (1987) Extracellular ATP increases cytosolic free calcium in thymocytes and initiates the blastogenesis of the phorbol 12-myristate 13-acetate-treated medullary population. Biochim Biophys Acta 927(3): 437-444.
158. Fishman RF, Rubin AL, Novogrodsky A, Stenzel KH (1980) Selective suppression of blastogenesis induced by different mitogens: effect of noncyclic adenosine-containing compounds. Cell Immunol 54(1): 129-139.
159. Gregory S, Kern M (1978) Adenosine and adenine nucleotides are mitogenic for mouse thymocytes. Biochem Biophys Res Commun 83(3): 1111-1116.
160. Huang N, Wang DJ, Heppel LA (1989) Extracellular ATP is a mitogen for 3T3, 3T6, and A431 cells and acts synergistically with other growth factors. Proc Natl Acad Sci U S A 86(20): 7904-7908.
161. Ikehara S, Pahwa RN, Lunzer DG, Good RA, Modak MJ (1981) Adenosine-5′-triphosphate-(ATP) mediated stimulation and suppression of DNA synthesis in lymphoid cells. I. Characterization of ATP responsive cells in mouse lymphoid organs. J Immunol 127(5): 1834-1838.
162. Barankiewicz J, Dosch HM, Cohen A (1988) Extracellular nucleotide catabolism in human B and T lymphocytes. The source of adenosine production. J Biol Chem 263(15): 7094-7098.
163. Corriden R, Insel PA, Junger WG (2007) A novel method using fluorescence microscopy for real-time assessment of ATP release from individual cells. Am J Physiol Cell Physiol 293(4): C1420-C1425.
164. Loomis WH, Namiki S, Ostrom RS, Insel PA, Junger WG (2003) Hypertonic stress increases T cell interleukin-2 expression through a mechanism that involves ATP release, P2 receptor, and p38 MAPK activation. J Biol Chem 278(7): 4590-4596.
165. Yip L, Cheung CW, Corriden R, Chen Y, Insel PA et al (2007) Hypertonic stress regulates T-cell function by the opposing actions of extracellular adenosine triphosphate and adenosine. Shock 27(3): 242-250.
166. Yip L, Woehrle T, Corriden R, Hirsh M, Chen Y et al (2009) Autocrine regulation of T-cell activation by ATP release and P2X7 receptors. FASEB J 23(6): 1685-1693.
167. Schenk U, Westendorf AM, Radaelli E, Casati A, Ferro M et al (2008) Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels. Sci Signal 1(39): ra6.
168. Woehrle T, Yip L, Manohar M, Sumi Y, Yao Y et al (2010) Hypertonic stress regulates T cell function via pannexin-1 hemichannels and P2X receptors. J Leukoc Biol 88(6): 1181-1189.
169. Schenk U, Frascoli M, Proietti M, Geffers R, Traggiai E et al (2011) ATP inhibits the generation and function of regulatory T cells through the activation of purinergic P2X receptors. Sci Signal 4(162): ra12.
170. Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A et al (2007) Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110(4): 1225-1232.
171. Wolberg G, Zimmerman TP, Hiemstra K, Winston M, Chu LC (1975) Adenosine inhibition of lymphocyte-mediated cytolysis: possible role of cyclic adenosine monophosphate. Science 187(4180): 957-959.
172. Wolberg G, Zimmerman TP, Duncan GS, Singer KH, Elion GB (1978) Inhibition of lymphocyte-mediated cytolysis by adenosine analogs. Biochemical studies concerning mechanism of action. Biochem Pharmacol 27(10): 1487-1495.
173. Blanchard DK, Wei S, Duan C, Pericle F, Diaz JI et al (1995) Role of extracellular adenosine triphosphate in the cytotoxic T-lymphocyte-mediated lysis of antigen presenting cells. Blood 85(11): 3173-3182.
174. Filippini A, Taffs RE, Sitkovsky MV (1990) Extracellular ATP in T-lymphocyte activation: possible role in effector functions. Proc Natl Acad Sci U S A 87(21): 8267-8271.
175. Tsukimoto M, Maehata M, Harada H, Ikari A, Takagi K et al (2006) P2X7 receptor-dependent cell death is modulated during murine T cell maturation and mediated by dual signaling pathways. J Immunol 177(5): 2842-2850.
176. Aswad F, Dennert G (2006) P2X7 receptor expression levels determine lethal effects of a purine based danger signal in T lymphocytes. Cell Immunol 243(1): 58-65.
177. Aswad F, Kawamura H, Dennert G (2005) High sensitivity of CD4+ CD25+ regulatory T cells to extracellular metabolites nicotinamide adenine dinucleotide and ATP: a role for P2X7 receptors. J Immunol 175(5): 3075-3083.
178. Jamieson GP, Snook MB, Thurlow PJ, Wiley JS (1996) Extracellular ATP causes of loss of l-selectin from human lymphocytes via occupancy of P2Z purinocepters. J Cell Physiol 166(3): 637-642.
179. Labasi JM, Petrushova N, Donovan C, McCurdy S, Lira P et al (2002) Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J Immunol 168(12): 6436-6445.
180. Smalley DM, Ley K (2005) l-selectin: mechanisms and physiological significance of ectodomain cleavage. J Cell Mol Med 9(2): 255-266.
181. Baricordi OR, Melchiorri L, Adinolfi E, Falzoni S, Chiozzi P et al (1999) Increased proliferation rate of lymphoid cells transfected with the P2X(7) ATP receptor. J Biol Chem 274(47): 33206-33208.
182. Adinolfi E, Callegari MG, Ferrari D, Bolognesi C, Minelli M et al (2005) Basal activation of the P2X7 ATP receptor elevates mitochondrial calcium and potential, increases cellular ATP levels, and promotes serum-independent growth. Mol Biol Cell 16(7): 3260-3272.
183. Gorini S, Callegari G, Romagnoli G, Mammi C, Mavilio D et al (2010) ATP secreted by endothelial cells blocks CX(3)CL 1-elicited natural killer cell chemotaxis and cytotoxicity via P2Y(1)(1) receptor activation. Blood 116(22): 4492-4500.
184. Schmidt A, Ortaldo JR, Herberman RB (1984) Inhibition of human natural killer cell reactivity by exogenous adenosine 5′-triphosphate. J Immunol 132(1): 146-150.
185. Dombrowski KE, Cone JC, Bjorndahl JM, Phillips CA (1995) Irreversible inhibition of human natural killer cell natural cytotoxicity by modification of the extracellular membrane by the adenine nucleotide analog 5′-p-(fluorosulfonyl)benzoyl adenosine. Cell Immunol 160(2): 199-204.
186. Krishnaraj R (1992) Negative modulation of human NK cell activity by purinoceptors. 1. Effect of exogenous adenosine triphosphate. Cell Immunol 141(2): 306-322.
187. Miller JS, Cervenka T, Lund J, Okazaki IJ, Moss J (1999) Purine metabolites suppress proliferation of human NK cells through a lineage-specific purine receptor. J Immunol 162(12): 7376-7382.
188. Beldi G, Banz Y, Kroemer A, Sun X, Wu Y et al (2010) Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice. Hepatology 51(5): 1702-1711.
189. Hogan SP, Rosenberg HF, Moqbel R, Phipps S, Foster PS et al (2008) Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 38(5): 709-750.
190. Burgers JA, Schweizer RC, Koenderman L, Bruijnzeel PL, Akkerman JW (1993) Human platelets secrete chemotactic activity for eosinophils. Blood 81(1): 49-55.
191. Ferrari D, Idzko M, Dichmann S, Purlis D, Virchow C et al (2000) P2 purinergic receptors of human eosinophils: characterization and coupling to oxygen radical production. FEBS Lett 486(3): 217-224.
192. Idzko M, Dichmann S, Panther E, Ferrari D, Herouy Y et al (2001) Functional characterization of P2Y and P2X receptors in human eosinophils. J Cell Physiol 188(3): 329-336.
193. Vanderstocken G, Bondue B, Horckmans M, Di Pietrantonio L, Robaye B et al (2010) P2Y2 receptor regulates VCAM-1 membrane and soluble forms and eosinophil accumulation during lung inflammation. J Immunol 185(6): 3702-3707.
194. Dichmann S, Idzko M, Zimpfer U, Hofmann C, Ferrari D et al (2000) Adenosine triphosphate-induced oxygen radical production and CD11b up-regulation: Ca(++) mobilization and actin reorganization in human eosinophils. Blood 95(3): 973-978.
195. Saito H, Ebisawa M, Reason DC, Ohno K, Kurihara K et al (1991) Extracellular ATP stimulates interleukin-dependent cultured mast cells and eosinophils through calcium mobilization. Int Arch Allergy Appl Immunol 94(1-4): 68-70.
196. Idzko M, Panther E, Bremer HC, Sorichter S, Luttmann W et al (2003) Stimulation of P2 purinergic receptors induces the release of eosinophil cationic protein and interleukin-8 from human eosinophils. Br J Pharmacol 138(7): 1244-1250.
197. Kobayashi T, Kouzaki H, Kita H (2010) Human eosinophils recognize endogenous danger signal crystalline uric acid and produce proinflammatory cytokines mediated by autocrine ATP. J Immunol 184(11): 6350-6358.
198. Uratsuji H, Tada Y, Kawashima T, Kamata M, Hau CS et al (2012) P2Y6 receptor signaling pathway mediates inflammatory responses induced by monosodium urate crystals. J Immunol 188(1): 436-444.
199. Jaffar ZH, Pearce FL (1993) Some characteristics of the ATP-induced histamine release from and permeabilization of rat mast cells. Agents Actions 40(1-2): 18-27.
200. Schulman ES, Glaum MC, Post T, Wang Y, Raible DG et al (1999) ATP modulates anti-IgE-induced release of histamine from human lung mast cells. Am J Respir Cell Mol Biol 20(3): 530-537.
201. Dahlquist R, Diamant B (1970) Further observations on ATP-induced histamine release from rat mast cells. Acta Pharmacol Toxicol (Copenh) 28(1): 43.
202. Dahlquist R (1974) Relationship of uptake of sodium and 45calcium to ATP-induced histamine release from rat mast cells. Acta Pharmacol Toxicol (Copenh) 35(1): 11-22.
203. Diamant B (1967) The mechanism of histamine release from rat mast cells induced by adenosine triphosphate. Acta Pharmacol Toxicol (Copenh) 25(S4): 33.
204. Kruger PG, Diamant B, Dahlquist R (1974) Morphological changes induced by ATP on rat mast cells and their relationship to histamine release. Int Arch Allergy Appl Immunol 46(5): 676-688.
205. Bennett JP, Cockcroft S, Gomperts BD (1981) Rat mast cells permeabilized with ATP secrete histamine in response to calcium ions buffered in the micromolar range. J Physiol 317: 335-345.
206. Cockcroft S, Gomperts BD (1979) ATP induces nucleotide permeability in rat mast cells. Nature 279(5713): 541-542.
207. Cockcroft S, Gomperts BD (1979) Activation and inhibition of calcium-dependent histamine secretion by ATP ions applied to rat mast cells. J Physiol 296: 229-243.
208. Peterson C (1974) Histamine release induced by compound 48-80 from isolated rat cells: dependence on endogenous ATP. Acta Pharmacol Toxicol (Copenh) 34(5): 356-367.
209. Johansen T, Chakravarty N (1972) Dependence of histamine release from rat mast cells on adenosine triphosphate. Naunyn Schmiedebergs Arch Pharmacol 275(4): 457-463.
210. Johansen T (1980) Further observations on the utilization of adenosine triphosphate in rat mast cells during histamine release induced by the ionophore A23187. Br J Pharmacol 69(4): 657-662.
211. Peterson C, Diamant B (1973) Utilization of endogenous ATP during histamine release from isolated rat mast cells. Agents Actions 3(3): 189-190.
212. Diamant B, Kruger PG (1967) Histamine release from isolated rat peritoneal mast cells induced by adenosine-5′-triphosphate. Acta Physiol Scand 71(4): 291-302.
213. Bradding P, Okayama Y, Kambe N, Saito H (2003) Ion channel gene expression in human lung, skin, and cord blood-derived mast cells. J Leukoc Biol 73(5): 614-620.
214. Wareham K, Vial C, Wykes RC, Bradding P, Seward EP (2009) Functional evidence for the expression of P2X1, P2X4 and P2X7 receptors in human lung mast cells. Br J Pharmacol 157(7): 1215-1224.
215. Gao ZG, Ding Y, Jacobson KA (2010) UDP-glucose acting at P2Y14 receptors is a mediator of mast cell degranulation. Biochem Pharmacol 79(6): 873-879.
216. Gao ZG, Wei Q, Jayasekara MP, Jacobson KA (2012) The role of P2Y(14) and other P2Y receptors in degranulation of human LAD2 mast cells. Purinergic Signal.
217. Dahlquist R, Diamant B (1974) Interaction of ATP and calcium on the rat mast cell: effect on histamine release. Acta Pharmacol Toxicol (Copenh) 34(5): 368-384.
218. Qian YX, McCloskey MA (1993) Activation of mast cell K+ channels through multiple G protein-linked receptors. Proc Natl Acad Sci U S A 90(16): 7844-7848.
219. Tatham PE, Lindau M (1990) ATP-induced pore formation in the plasma membrane of rat peritoneal mast cells. J Gen Physiol 95(3): 459-476.
220. Sudo N, Tanaka K, Koga Y, Okumura Y, Kubo C et al (1996) Extracellular ATP activates mast cells via a mechanism that is different from the activation induced by the cross-linking of Fc receptors. J Immunol 156(10): 3970-3979.
221. Gao ZG, Ding Y, Jacobson KA (2010) P2Y(13) receptor is responsible for ADP-mediated degranulation in RBL-2H3 rat mast cells. Pharmacol Res 62(6): 500-505.
222. Bulanova E, Bulfone-Paus S (2010) P2 receptor-mediated signaling in mast cell biology. Purinergic Signal 6(1): 3-17.
223. Osipchuk Y, Cahalan M (1992) Cell-to-cell spread of calcium signals mediated by ATP receptors in mast cells. Nature 359(6392): 241-244.
224. Carroll WA, Donnelly-Roberts D, Jarvis MF (2009) Selective P2X(7) receptor antagonists for chronic inflammation and pain. Purinergic Signal 5(1): 63-73.
225. Romagnoli R, Baraldi PG, Cruz-Lopez O, Lopez-Cara C, Preti D et al (2008) The P2X7 receptor as a therapeutic target. Expert Opin Ther Targets 12(5): 647-661.
226. Arulkumaran N, Unwin RJ, Tam FW (2011) A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases. Expert Opin Investig Drugs 20(7): 897-915.
227. Accurso FJ, Moss RB, Wilmott RW, Anbar RD, Schaberg AE et al (2011) Denufosol tetrasodium in patients with cystic fibrosis and normal to mildly impaired lung function. Am J Respir Crit Care Med 183(5): 627-634.
228. Burnstock G (2006) Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev 58(1): 58-86.
229. Cattaneo M (2007) Platelet P2 receptors: old and new targets for antithrombotic drugs. Expert Rev Cardiovasc Ther 5(1): 45-55.
230. White N, Burnstock G (2006) P2 receptors and cancer. Trends Pharmacol Sci 27(4): 211-217.
231. Di Virgilio F (2012) Purines, purinergic receptors, and cancer. Cancer Res 72(21): 5441-5447.
232. Nakamura M, Imanaka T, Sakamoto A (2012) Diquafosol ophthalmic solution for dry eye treatment. Adv Ther 29(7): 579-589.
233. Ford AP, Gever JR, Nunn PA, Zhong Y, Cefalu JS et al (2006) Purinoceptors as therapeutic targets for lower urinary tract dysfunction. Br J Pharmacol 147(Suppl 2): S132-S143.
234. Cattaneo M (2010) New P2Y(12) inhibitors. Circulation 121(1): 171-179.
235. Wartak SA, Lotfi A, Rothberg M (2009) Ticagrelor versus clopidogrel in acute coronary syndromes. N Engl J Med 361(24): 2386-2387.
236. Gum RJ, Wakefield B, Jarvis MF (2012) P2X receptor antagonists for pain management: examination of binding and physicochemical properties. Purinergic Signal 8(Suppl 1): 41-56.
237. Jacobson KA, Boeynaems JM (2010) P2Y nucleotide receptors: promise of therapeutic applications. Drug Discov Today 15(13-14): 570-578.